Who Supplies Streptomycin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Streptomycin exports, with 57+ registered manufacturers shipping to buyers across 36+ countries — yet a handful of companies dominate the shipments. ASHISH LIFE SCIENCE PRIVATE LIMITED holds the largest share at 17.5% (export value: $100.6K). Close behind, MACLEODS PHARMACEUTICALS LTD (16.1%, $92.5K). EVOLET HEALTHCARE PRIVATE LIMITED (8.2%, $46.8K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Streptomycin? Top Manufacturers & Their Buyers
Flow of Streptomycin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Streptomycin Supplier Network — Key Market Intelligence
The Streptomycin export market from India is led by ASHISH LIFE SCIENCE PRIVATE LIMITED, which alone commands a 17.5% share, shipping $100.6K worth of product across 3 shipments. The second-largest exporter, MACLEODS PHARMACEUTICALS LTD, contributes $92.5K (16.1%) to the overall market. Combined, the top two suppliers alone account for 33.7% of all Streptomycin exports, indicating a relatively concentrated supply base.
Across all 57 tracked manufacturers, the total Streptomycin export value stands at $573.8K from 150 shipments. The market average shipment value is $3.8K. The single largest buyer relationship in terms of trade value is BANQUE SAUDI FRANSI, receiving $100.6K worth of product.
The combined buyer network spans 3 named purchasing companies, including BANQUE SAUDI FRANSI, M/S ARABIAN ETHICALS CO. (ETHIX, ASIAPHARM LLC.. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1ASHISH LIFE SCIENCE PRIVATE LIMITED
ASHISH LIFE SCIENCE PRIVATE LIMITED is the first-largest Streptomycin exporter from India, with a market share of 17.5% and a total export value of $100.6K across 3 shipments. Their average shipment value of $33.5K is above the market average of $3.8K, suggesting premium or bulk contract pricing.
ASHISH LIFE SCIENCE PRIVATE LIMITED serves 1 named buyer in our database. BANQUE SAUDI FRANSI is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• BANQUE SAUDI FRANSI — $100.6K across 3 shipments (100.0% of this supplier's total exports)
Key Insight: ASHISH LIFE SCIENCE PRIVATE LIMITED's per-shipment value of $33.5K is 777% above the market average of $3.8K, consistent with large-order contracts or value-added formulations.
2MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the second-largest Streptomycin exporter from India, with a market share of 16.1% and a total export value of $92.5K across 5 shipments. Their average shipment value of $18.5K is above the market average of $3.8K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 2 named buyers in our database. M/S ARABIAN ETHICALS CO. (ETHIX is the dominant customer, accounting for 67.1% of this supplier's tracked business. Top customers include:
• M/S ARABIAN ETHICALS CO. (ETHIX — $62.1K across 3 shipments (67.1% of this supplier's total exports)
• M/S ARABIAN ETHICALS CO. (ETHIX — $30.5K across 2 shipments (32.9% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $18.5K is 384% above the market average of $3.8K, consistent with large-order contracts or value-added formulations.
3EVOLET HEALTHCARE PRIVATE LIMITED
EVOLET HEALTHCARE PRIVATE LIMITED is the third-largest Streptomycin exporter from India, with a market share of 8.2% and a total export value of $46.8K across 3 shipments. Their average shipment value of $15.6K is above the market average of $3.8K, suggesting premium or bulk contract pricing.
EVOLET HEALTHCARE PRIVATE LIMITED serves 2 named buyers in our database. TO THE ORDER OF is the dominant customer, accounting for 67.9% of this supplier's tracked business. Top customers include:
• TO THE ORDER OF — $31.8K across 2 shipments (67.9% of this supplier's total exports)
• To The Order — $15.0K across 1 shipments (32.1% of this supplier's total exports)
Key Insight: EVOLET HEALTHCARE PRIVATE LIMITED's per-shipment value of $15.6K is 308% above the market average of $3.8K, consistent with large-order contracts or value-added formulations.
4ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED
ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED is the fourth-largest Streptomycin exporter from India, with a market share of 3.9% and a total export value of $22.4K across 3 shipments. Their average shipment value of $7.5K is above the market average of $3.8K, suggesting premium or bulk contract pricing.
ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED serves 2 named buyers in our database. ASIAPHARM LLC. is the dominant customer, accounting for 50.5% of this supplier's tracked business. Top customers include:
• ASIAPHARM LLC. — $11.3K across 2 shipments (50.5% of this supplier's total exports)
• ASIAPHARM LLC. — $11.1K across 1 shipments (49.5% of this supplier's total exports)
Key Insight: ZENEX ANIMAL HEALTH INDIA PRIVATE LIMITED's per-shipment value of $7.5K is 95% above the market average of $3.8K, consistent with large-order contracts or value-added formulations.
5LABORATE PHARMACEUTICALS INDIA LTD
LABORATE PHARMACEUTICALS INDIA LTD is the fifth-largest Streptomycin exporter from India, with a market share of 0.0% and a total export value of $0 across 4 shipments. Their average shipment value of $0 is below the market average of $3.8K, reflecting a high-volume, competitive pricing strategy.
Key Insight: LABORATE PHARMACEUTICALS INDIA LTD operates with high shipment frequency (4 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.
6SWISS PARENTERALS LIMITED
SWISS PARENTERALS LIMITED is the fifth-largest Streptomycin exporter from India, with a market share of 0.0% and a total export value of $0 across 5 shipments. Their average shipment value of $0 is below the market average of $3.8K, reflecting a high-volume, competitive pricing strategy.
Key Insight: SWISS PARENTERALS LIMITED operates with high shipment frequency (5 shipments) at a per-shipment value of $0, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Streptomycin Flows
Once Streptomycin leaves the manufacturing plants of companies like ASHISH LIFE SCIENCE PRIVATE LIMITED and MACLEODS PHARMACEUTICALS LTD, it travels to 5 destination markets with a combined import value of $573.8K. Saudi Arabia absorbs the largest share at 28.9% ($165.7K), followed by Nigeria (22.2%) and United Arab Emirates (17.1%).
In Saudi Arabia — the top destination — named importers include BANQUE SAUDI FRANSI. In Nigeria, key buyers are EMBASSY PHARMACEUTICAL AND.
This geographic spread reflects Streptomycin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Streptomycin Go? Top Importing Countries & Their Buyers
Trade flow of Streptomycin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Saudi Arabia
Saudi Arabia ranks as the first-largest destination for Streptomycin imports from India, with a total trade value of $165.7K across 7 shipments — representing a 28.9% share of all Streptomycin exports. The average shipment value of $23.7K is above the global average of $3.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Streptomycin importers in Saudi Arabia: BANQUE SAUDI FRANSI is the largest buyer, accounting for 96.3% ($159.6K) of this market's total imports.
• BANQUE SAUDI FRANSI — $159.6K (96.3% of Saudi Arabia's total)
Key Insight: Saudi Arabia's per-shipment average of $23.7K (519% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Saudi Arabia is a key market for Streptomycin imports from India.
2Nigeria
Nigeria ranks as the second-largest destination for Streptomycin imports from India, with a total trade value of $127.3K across 4 shipments — representing a 22.2% share of all Streptomycin exports. The average shipment value of $31.8K is above the global average of $3.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Streptomycin importers in Nigeria: EMBASSY PHARMACEUTICAL AND is the largest buyer, accounting for 100.0% ($127.3K) of this market's total imports.
• EMBASSY PHARMACEUTICAL AND — $127.3K (100.0% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $31.8K (732% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Streptomycin imports from India.
3United Arab Emirates
United Arab Emirates ranks as the third-largest destination for Streptomycin imports from India, with a total trade value of $98.1K across 7 shipments — representing a 17.1% share of all Streptomycin exports. The average shipment value of $14.0K is above the global average of $3.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Streptomycin importers in United Arab Emirates: M/S ARABIAN ETHICALS CO. (ETHIX is the largest buyer, accounting for 63.3% ($62.1K) of this market's total imports.
• M/S ARABIAN ETHICALS CO. (ETHIX — $62.1K (63.3% of United Arab Emirates's total)
• VIP SHIPPING LLC — $4.2K (4.2% of United Arab Emirates's total)
• ZMC EXPRESS CARGO FZCO — $1.1K (1.2% of United Arab Emirates's total)
Key Insight: United Arab Emirates's per-shipment average of $14.0K (266% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Streptomycin imports from India.
4Tajikistan
Tajikistan ranks as the fourth-largest destination for Streptomycin imports from India, with a total trade value of $67.9K across 4 shipments — representing a 11.8% share of all Streptomycin exports. The average shipment value of $17.0K is above the global average of $3.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Streptomycin importers in Tajikistan: ASIAPHARM LLC is the largest buyer, accounting for 46.8% ($31.8K) of this market's total imports.
• ASIAPHARM LLC — $31.8K (46.8% of Tajikistan's total)
• ASIAPHARM LLC. — $23.5K (34.7% of Tajikistan's total)
Key Insight: Tajikistan's per-shipment average of $17.0K (344% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Tajikistan is a key market for Streptomycin imports from India.
5Algeria
Algeria ranks as the fifth-largest destination for Streptomycin imports from India, with a total trade value of $46.8K across 0 shipments — representing a 8.2% share of all Streptomycin exports. The average shipment value of $46.8K is above the global average of $3.8K, indicating high-value procurement contracts or branded formulations.
Key Insight: Algeria's per-shipment average of $46.8K (1123% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Algeria is a key market for Streptomycin imports from India.
People Also Ask — Streptomycin Supplier & Trade Network
Who are the top suppliers of Streptomycin from India?+
Which companies buy Streptomycin from Indian manufacturers?+
Where does Streptomycin exported from India go?+
What is the market share of the top Streptomycin supplier from India?+
What is the average shipment value for Streptomycin exports from India?+
Is Streptomycin manufactured in India and exported globally?+
Which country imports the most Streptomycin from India?+
Who are the buyers of Streptomycin in Nigeria?+
How concentrated is the Streptomycin supplier market in India?+
How do I find verified buyers for Streptomycin in specific countries?+
Streptomycin Trade Network — Key Takeaways
- 1ASHISH LIFE SCIENCE PRIVATE LIMITED is India's dominant Streptomycin exporter with a 17.5% market share and $100.6K in total exports — making it the single most important sourcing entity in this market.
- 2The top 57 suppliers collectively account for 45.7% of all tracked Streptomycin exports, with a combined trade value of $573.8K.
- 3Saudi Arabia is the largest destination market, absorbing 28.9% of India's Streptomycin exports ($165.7K). Nigeria (22.2%) and United Arab Emirates (17.1%) follow.
- 4With 150 total shipments averaging $3.8K each, the Streptomycin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include BANQUE SAUDI FRANSI, M/S ARABIAN ETHICALS CO. (ETHIX, M/S ARABIAN ETHICALS CO. (ETHIX, ASIAPHARM LLC. — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 1 customers
6 suppliers → 36 countries
Network value: $573.8K
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Streptomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Streptomycin.
- 2.Flow Mapping: 57 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 150 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 36 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
150 Verified Shipments
57 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists